HM
HealthCor Management Portfolio holdings
AUM
$109M
This Quarter Return
+15.92%
1 Year Return
+11.46%
3 Year Return
+50.01%
5 Year Return
+144.68%
10 Year Return
–
AUM
$1.62B
AUM Growth
+$1.62B
(+2.2%)
Cap. Flow
-$175M
Cap. Flow
% of AUM
-10.83%
Top 10 Holdings %
Top 10 Hldgs %
47.55%
Holding
79
New
28
Increased
9
Reduced
15
Closed
20
Top Buys
| 1 |
Biogen
BIIB
|
$80.5M |
| 2 |
AET
Aetna Inc
AET
|
$74.6M |
| 3 |
Jazz Pharmaceuticals
JAZZ
|
$56.2M |
| 4 |
Teva Pharmaceuticals
TEVA
|
$54M |
| 5 |
Brookdale Senior Living
BKD
|
$52.7M |
Top Sells
| 1 |
Gilead Sciences
GILD
|
$116M |
| 2 |
Bausch Health
BHC
|
$93M |
| 3 |
Pfizer
PFE
|
$79.9M |
| 4 |
Keysight
KEYS
|
$69M |
| 5 |
MNK
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
|
$66.5M |
Sector Composition
| 1 | Healthcare | 78.83% |
| 2 | Financials | 4.62% |
| 3 | Technology | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
HZNP
1
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $104M | 4.96% | 4,000,000 -1,600,000 | -29% | -$41.6M |
|
|
MNK
2
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
| $101M | 4.83% | 800,000 -525,000 | -40% | -$66.5M |
|
3
Labcorp
LH
$23.1B
| $85.1M | 4.06% | 675,000 +125,000 | +23% | +$15.8M |
|
|
4
Biogen
BIIB
$19.4B
| $80.5M | 3.84% | +190,700 | New | +$80.5M |
|
|
AET
5
DELISTED
Aetna Inc
AET
| $74.6M | 3.56% | +700,000 | New | +$74.6M |
|
|
6
Brookdale Senior Living
BKD
$1.83B
| $73.6M | 3.51% | 1,950,000 +1,396,500 | +252% | +$52.7M |
|
|
7
Teva Pharmaceuticals
TEVA
$21.1B
| $71.6M | 3.42% | 1,150,000 +866,000 | +305% | +$54M |
|
8
Viatris
VTRS
$12.3B
| $68M | 3.25% | 1,146,400 +447,600 | +64% | +$26.6M |
|
|
9
Jazz Pharmaceuticals
JAZZ
$7.75B
| $56.2M | 2.68% | +325,000 | New | +$56.2M |
|
|
TSRO
10
DELISTED
TESARO, Inc.
TSRO
| $53.1M | 2.53% | 925,000 -125,000 | -12% | -$7.18M |
|
|
MDVN
11
DELISTED
MEDIVATION, INC.
MDVN
| $48.4M | 2.31% | 375,000 -200,000 | -35% | -$25.8M |
|
|
KND
12
DELISTED
Kindred Healthcare
KND
| $46.6M | 2.23% | +1,960,800 | New | +$46.6M |
|
|
RAD
13
DELISTED
Rite Aid Corporation
RAD
| $45.7M | 2.18% | +5,262,900 | New | +$45.7M |
|
14
Boston Scientific
BSX
$156B
| $42.4M | 2.02% | 2,386,700 -1,074,500 | -31% | -$19.1M |
|
15
Merck
MRK
$210B
| $41.3M | 1.97% | +719,000 | New | +$41.3M |
|
|
ALR
16
DELISTED
Alere Inc
ALR
| $39.1M | 1.87% | +799,900 | New | +$39.1M |
|
|
WBMD
17
DELISTED
WebMD Health Corp.
WBMD
| $37.5M | 1.79% | 855,555 -369,445 | -30% | -$16.2M |
|
18
Illumina
ILMN
$15.8B
| $36M | 1.72% | 194,100 -155,900 | -45% | -$28.9M |
|
19
Edwards Lifesciences
EW
$47.8B
| $35.6M | 1.7% | +250,000 | New | +$35.6M |
|
|
BCR
20
DELISTED
CR Bard Inc.
BCR
| $33.5M | 1.6% | +200,000 | New | +$33.5M |
|
21
Vertex Pharmaceuticals
VRTX
$100B
| $32.4M | 1.55% | +275,000 | New | +$32.4M |
|
|
22
Pfizer
PFE
$141B
| $32.1M | 1.53% | 923,200 -2,295,900 | -71% | -$79.9M |
|
|
RLYP
23
DELISTED
RELYPSA INC COM
RLYP
| $31.6M | 1.51% | +875,000 | New | +$31.6M |
|
24
Avanos Medical
AVNS
$554M
| $30.5M | 1.46% | 620,800 -330,000 | -35% | -$16.2M |
|
|
PDCO
25
DELISTED
Patterson Companies, Inc.
PDCO
| $27.8M | 1.33% | +570,000 | New | +$27.8M |
|